BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Research output: Contribution to journalReview article

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)e68-e88
JournalTH Open
Volume02
Issue number1
DOIs
Publication statusPublished - 2018

Keywords

  • BCR-ABL
  • arterial thrombotic events
  • tyrosine kinase inhibators
  • chronic myeloid leukemia

Cite this